Vesicoureteral reflux - Current treatment options

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 11, 2003, Pages 1959-1966

  Greenfield, Saul P ^a  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Antibiotic prophylaxis; Anticholinergies; Cystoscopic bulking agents; Pyelonephritis; Urinary tract infection; Vesicoureteral reflux; Voiding dysfuntion

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; COTRIMOXAZOLE; LAXATIVE; NITROFURANTOIN; OXYBUTYNIN; TOLTERODINE; TRIMETHOPRIM; URINARY TRACT AGENT; URINARY TRACT ANTIINFECTIVE AGENT;

AMBULATORY SURGERY; ANESTHESIOLOGICAL TECHNIQUES; CONSTIPATION; COST OF ILLNESS; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DRUG COST; DRUG USE; GRANULOCYTOPENIA; HIGH RISK POPULATION; HUMAN; MASS SCREENING; MICTURITION DISORDER; MORBIDITY; PYELONEPHRITIS; RECURRENT INFECTION; REVIEW; STOMACH DISEASE; URINARY TRACT INFECTION; URINARY TRACT SURGERY; VAGINITIS; VESICOURETERAL REFLUX; XEROSTOMIA;

EID: 0242659185     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.11.1959     Document Type: Review

References (69)

1. GREENFIELD SP, WAN J: The diagnosis and medical management of primary vesicoureteral reflux. In: Pediatric Urology. Gearhart JP, Rink RC, Mouriquand PDE, (Eds). WB Saunders Co., Philadelphia, USA (2001):382-410.
2. GREENFIELD SP: Management of vesicoureteral reflux in children. Current Urology Reports (2001) 2:113-121.
3. WOODWELL DA: Office visits to urologists: United States 1989 - 1990. Advance data from vital and health statistics; no. 234. Hyattsville (MD): National Center for Health Statistics. (1993):1-9.
4. GREENFIELD SP, NG M, WAN J: Experience with vesicoureteral reflux in children: clinical characteristics. J. Urol. (1997) 158:574-577.
5. BAKSHANDEH K, LYNNE C, CARRION H: Vesicoureteral reflux and end stage renal disease. Int. J. Urol. (1976) 116:557-558.
6. KINCAID-SMITH P, BASTOS MG, BECKER GJ: Reflux nephropathy in the adult. In: Reflux Nephropathy Update. Hodson CJ, Heptinstall RH, Winberg J (Eds), S Karger, Basel, Switzerland (1984):94-101.
7. STILL JL, COTTOM D: Severe hypertension in children. Arch. Dis. Child. (1967) 42:34-39.
8. LONDE S: Causes of hypertension in the young. Pediatr. Clin. North Am. (1978) 25:55-65.
9. VALLEE JP, VALLEE MP, GREENFIELD SP: Contemporary incidence of morbidity related to vesicoureteral reflux. Urology (1999) 53:812-815.
10. WARADY BA, HERBERT D, SULLIVAN EK: Annual report of the North American Pediatric Renal Transplant Cooperative Study Pediatric Nephrology (1997) 11:49-64.
11. WAN J, GREENFIELD SP, NG M: Sibling reflux: a dual center retrospective study. J. Urol. (1996) 156:677-679.
12. ZERIN M, RITCHEY ML, CHANG ACH: Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and renal anomalies. Radiology (1993) 187:157-160.
13. WAN J, GREENFIELD SP, TALLEY M: An analysis of social and economic factors associated with follow up of patients with vesicouretral reflux. J. Urol. (1996) 156:668-672.
14. GREENFIELD SP, WAN J: Vesicoureteral reflux: practical aspects of evaluation and management. Pediatr. Nephrol. (1996) 10:789-794.
15. DITCHFIELD MR, DE CAMPO JF, NOLAN TM: Risk factors in the development of early renal cortical defects in children with urinary tract infection. Am. J. Roentgenol. (1994) 162:1393-1397.
16. WINBERG J: Progressive renal damage from infection with or without reflux (commentary). J Urol. (1992) 148:1733-1734.
17. BIRMINGHAM REFLUX STUDY GROUP: Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Br. Med. J. (1987) 295:237-241.
18. SMELLIE JM, POULTON A, PRESCOD N: Retrospective study of children with renal scarring associated with reflux and urinary tract infection. Br. Med. J. (1994) 308:1193-1196.
19. SHIMADA K, MATSUI T, OGINO T: Renal growth and progression of reflux nephropathy in children with vesicoureteral reflux. J. Urol. (1988) 140:1097-1100.
20. NASSEER SR, STEINHARDT GF: New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation. J Urol. (1997) 158:566-568.
21. COOPER CS, CHUNG BI, KIRSCH AJ: The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J. Urol. (2000) 163:269-273.
22. THOMPSON RH, CHEN JJ, PUGATCH J: Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J. Urol. (2001) 166:1465-1469.
23. SILLEN U, BACHELARD M, HERMANSON G: Gross bilateral reflux in infants: gradual decrease of initial detrusor hypercontractility. J. Urol. (1996) 155:668-672.
24. WAN J, KAPLINSKY R, GREENFIELD SP: Toilet habits of children evaluated for urinary tract infection. J. Urol. (1995) 154:797-799.
25. KOFF SA: Relationship between dysfunctional voiding and reflux. J. Urol. (1992) 148:1703-1705.
26. SILLEN U: Bladder dysfunction in children with vesicoureteral reflux. Acta. Paediatr. Suppl. (1999) 431:40-47.
27. SOYGER T, ARIKAN N, YESILLI C: Relationship among pediatric voiding dysfunction and vesicoureteral reflux and renal scars. Urology (1999) 54:905-908.
28. KOFF SA, WAGNER TT, JAYANTHI VR: The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux, and urinary tract infections in children. J. Urol. (1998) 160:1019-1022.
29. WILLEMSEN J, NIJMAN RJM: Vesicoureteral reflux and videourodynamic studies: results of a prospective study. Urology (2000) 55:939-943.
30. CHANDRA M, MADDIX H: Urodynamic dysfunction in infants with vesicoureteral reflux. J. Pediatr. (2000) 136:754-759.
31. SCHOLTMEIJER RJ, NIJMAN RJ: Vesicoureteral reflux and videourodynamic studies: results of a prospective study after three years of follow up. Urology (1994) 43:714-718.
32. MUNDING M, WESSELS H, THORNBERRY B: Use of tolterodine in children with dysfunctional voiding: an initial report. J. Urol. (2001) 165:926-928.
33. GLEASON DM, SUSSET J, WHITE C: Evaluation of a new once daily formulation of oxybutynin for the treatment of urinary urge incontinence. Urology (1999) 54:420-423.
34. DMOCHOWSKI RR, DAVILA GW, ZINNER NR: Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J. Urol. (2002) 168: 580-586.
35. PARK JM, RETIK AB: Surgery for vesicoureteral reflux. In: Pediatric Urology. Gearhart JP, Rink RC, Mouriquand PDE, (Eds), WB Saunders Co., Philadelphia, USA (2001):421-429.
36. ELDER J: Guidelines for consideration for surgical repair of vesicoureteral reflux. Curr. Opin. Urol. (2000) 10:579-585.
37. LAKSHMANAN Y, FUNG LCT: Laparoscopic extravesicular ureteral reimplantation for vesicoureteral reflux: recent technical advances. J. Endourol. (2000) 14: 589-594.
38. OKAMURA K, KATO N, TSUJI, Y: A comparative study of endoscopic trigonoplasty for vesicoureteral reflux in children and in adults. Int. J. Urol. (1999) 6:562-566.
39. STENBERG A, HENSLE TW, LACKGREN G: Vesicoureteral reflux: a new treatment algorithm. Curr. Urol. Rep. (2002) 3:107-114.
40. O'DONNELL B, PURI P: Treatment of vesicoureteral reflux by endoscopic injection of Teflon. Br. Med. J. (1984) 289:7-9.
41. CHERTIN B, COLHOUN E, MURGESH V: Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. J. Urol. (2002) 167:1443-1446.
42. PURI P: Endoscopic correction of vesicoureteral reflux. Curr. Opin. Urol. (2000) 10:593-597.
43. HUGHES PD: Ureteric reflux in adults and children treated exclusively by endoscopic Teflon injection: a 10-year experience. Aust. NZJ. Surg. (1999) 69:856-859.
44. STEYAERT H, SATTONET C, BLOCH C: Migration of PTFE paste particles to the kidney after treatment for vesico-ureteric reflux. BJU Int. (2000) 85:168-169.
45. KERSHEN RT, ATALA A: New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol. Clin. N. Amer. (1999) 26:81-94.
46. DE GRAZIA E, CIMADOR M: Long term follow-up results of vesico-ureteral reflux treated with subureteral collagen injection (SCIN). Min. Pediatr. (2003) 52:7-14.
47. INOUE K, NAKAMOTO T. USUI A: Endoscopic subureteral gluteraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults. J. Urol. (2000) 164:336-339.
48. HAFERKAMP A, CONTRACTOR H, MOHRING K: Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up. Urology (2000) 55:759-763.
49. HAFERKAMP A, MOHRING K, STAEHLER G: Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. J. Urol. (2000) 163:274-277.
50. HAFERKAMP A, MOHRING K, STAEHLER G: Pitfalls of repeat subureteral bovine collagen injections for endoscopic treatment of vesicouretertal reflux. J. Urol. (2000) 163:1919-1921.
51. TSUBOI N, HORIUC HI K, OSAWA S: Endoscopic treatment of vesicoureteral reflux in children with gluteraldehyde cross-linked bovine dermal collagen. J. Nippon Med. Sch. (2000) 67:9-12.
52. CAPOZZA N, PATRICOLO M, LAIS A: Endoscopic treatment of vesico-ureteric reflux: twelve years' experience. Urol. Int. 67:228-231.
53. PALMA PC, RICCETTO CL, HERRMANN V: Repeated lipoinjections; for stress urinary incontinence. J. Endourol. (1997) 11:67.
54. KERSHEN RT, FEFER SD, ATALA A: Tissue-engineered therapies for the treatment of urinary incontinence and vesicoureteral reflux. World J. Urol. (2000) 18:51-55.
55. DIAMOND DA, CALDAMONE AA: Endoscopic treatment of vesicoureteric reflux in children using autologous chondrocyte: preliminary results. J. Urol. (1999) 162:1185-1188.
56. MCHEIK JN, BACQUEY C, VERGNES P: Phagocytic reaction in contact with macroplastic: application in pediatric surgery. J. Ped. Surg. (2000) 35:1474-1477.
57. OSWALD J, RICCABONA M, LUSUARDI L: Prospective comparison and 1-year follow-up of a single endoscopic subureteral polymethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology (2002) 60:894-898.
58. GIACOMELLO L, CAMOGLIO ES, CECCHETO M: Endoscopic treatment of vesico-ureteral reflux and urinary incontinence. Ped. Med. Chir. (2002) 24:134-136.
59. CAPOZZA N, CAIONE P: Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a comparison with antibiotic prophylaxis. J. Peds. (2002) 140:230-234.
60. STENBERG AM, LACKGREN G: A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short term clinical results. J. Urol. (1995) 154:800-803.
61. STENBERG A, LARSSON E, LACKGREN G: Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J. Urol. (2003) 169:1109-1113.
62. LACKGREN G, WAHLIN N, STENBERG A: Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr. Suppl. (1999) 431:62-71.
63. LACKGREN G, WAHLIN N, SKOLDENBERG E: Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J. Urol. (2001) 166:1887-1892.
64. KIRSCH AJ, PEREZ-BRAYFIELD MR, SCHERZ HC: Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospital of Atlanta experience. J. Urol. (2003) 170:211-215.
65. ELDER J, PETERS CA ARANT BS: Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J. Urol. (1997) 157:1846-1851.
66. MATHEWS R, NASLUND M, DOCIMO S: Cost analysis of the treatment of vesicoureteral reflux: a computer model. J. Urol. (2000) 163:561-566.
67. KOBELT G, CANNING DA, HENSLE TW: The cost effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J. Urol. (2003) 169:1480-1485.
68. POLITANO V: Vesicoureteral reflux. In: Urologic Surgery. Glenn JF (Ed.). Harper & Row, New York, USA (1975):272-293.
69. WALKER RD: Vesicoureteral reflux In: Adult and Pediatric Urology, (Vol 2). Gillenwater JW, Grayhack JT, Howards SS (Eds), Year Book Medical Publishers, Chicago, USA (1987):1676-1708.